Austin, TX, United States of America

Keith A Friedman

This inventor holds 51 USPTO granted patents and 42 published patent applications and 3 EPO patents, primarily in Analyte Monitoring Devices (CPC class A61B). Top assignees: Abbott Diabetes Care Inc., Therasense, Inc., The University of Texas System. Active years: 2001-2021.

USPTO Granted Patents = 51 

% Patents Active = 21.6

 

Average Co-Inventor Count = 7.8

ph-index = 21

Forward Citations = 9,699(Granted Patents)

Forward Citations (Not Self Cited) = 9,332(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 2001-2021

Loading Chart...
Loading Chart...
Areas of Expertise:
Analyte Monitoring
Organic Acid Salts
Graphene Rich Carbons
Low-Temperature Pyrolysis
Occupants Rollover Protection
Device Methods
Carbon Materials
Safety Innovations
51 patents (USPTO):Explore Patents

Title: Keith A Friedman - Pioneering Inventor from Austin, TX

Introduction: Keith A Friedman is a renowned inventor based in Austin, Texas, known for his groundbreaking contributions to various industries.

Latest Patents: Keith A Friedman holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Keith A Friedman has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Keith A Friedman has collaborated with leading companies, research institutions, and universities to bring his inventions to life, fostering a culture of creativity and excellence in the industry.

Conclusion: Keith A Friedman's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…